Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Patent claims relating to use of Avant's TP-20 in stroke allowed

Dec. 17, 1998

Another market launch for Orion's COMT inhibitor

Dec. 17, 1998

Zeneca's new pain-relieving agents revealed in patent literature

Dec. 17, 1998

Studies using 5-ht6 antagonist Ro-04-6790 provide new clues about receptor function

Dec. 17, 1998

NPS Pharmaceuticals updates epilepsy program

Dec. 17, 1998

Novel glutamate receptor antagonist shows excellent potential as antiepileptic agent

Dec. 15, 1998

Merckle launches new treatment for narcolepsy in Germany

Dec. 15, 1998

New U.S. patent provides Cortex exclusivity for Ampakine compounds

Dec. 14, 1998

Another series of adenosine kinase inhibitors patented by Abbott

Dec. 11, 1998

Quinolinomorphinans for ischemic, hemorrhagic, traumatic or degenerative brain disorders

Dec. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...